Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy
Open Access
- 15 November 2022
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-17
Abstract
Alterations of serine/threonine phosphorylation of the cardiac proteome are a hallmark of heart failure. However, the contribution of tyrosine phosphorylation (pTyr) to the pathogenesis of cardiac hypertrophy remains unclear. We use global mapping to discover and quantify site-specific pTyr in two cardiac hypertrophic mouse models, i.e., cardiac overexpression of ErbB2 (TgErbB2) and α myosin heavy chain R403Q (R403Q-αMyHC Tg), compared to control hearts. From this, there are significant phosphoproteomic alterations in TgErbB2 mice in right ventricular cardiomyopathy, hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM) pathways. On the other hand, R403Q-αMyHC Tg mice indicated that the EGFR1 pathway is central for cardiac hypertrophy, along with angiopoietin, ErbB, growth hormone, and chemokine signaling pathways activation. Surprisingly, most myofilament proteins have downregulation of pTyr rather than upregulation. Kinase-substrate enrichment analysis (KSEA) shows a marked downregulation of MAPK pathway activity downstream of k-Ras in TgErbB2 mice and activation of EGFR, focal adhesion, PDGFR, and actin cytoskeleton pathways. In vivo ErbB2 inhibition by AG-825 decreases cardiomyocyte disarray. Serine/threonine and tyrosine phosphoproteome confirm the above-described pathways and the effectiveness of AG-825 Treatment. Thus, altered pTyr may play a regulatory role in cardiac hypertrophic models.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K01-HL13368-01)
- American Heart Association (AHA 15GRNT25720026)
This publication has 57 references indexed in Scilit:
- 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput dataBMC Bioinformatics, 2012
- Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in MicePLOS ONE, 2012
- Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissuesNature Communications, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathyProgress in Pediatric Cardiology, 2011
- Calcium sensitivity, force frequency relationship and cardiac troponin I: Critical role of PKA and PKC phosphorylation sitesJournal of Molecular and Cellular Cardiology, 2010
- Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyCirculation: Cardiovascular Genetics, 2009
- Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesionBMC Cancer, 2009
- Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature DeathMolecular and Cellular Biology, 2009
- Plakophilin 2: a critical scaffold for PKCα that regulates intercellular junction assemblyJournal of Cell Biology, 2008